-
EASD 2025: Viperin signals a path to targeted beta‑cell preservation in T1D
18 Sep 2025 11:26 GMT
… alpha, interleukin‑1 beta, and interferon‑gamma, trigger beta‑cell stress and … a pharmaceutical strategy perspective, the next step is short treatment bursts … and complement beta‑cell restoration approaches. Over time, precision interferon‑pathway modulation …
-
Saphnelo self─administration TULIP─SC phase III trial meets primary endpoint in patients with systemic lupus erythematosus based on an interim analysis
18 Sep 2025 04:58 GMT
… Health Network, Professor of Medicine at Drexel University College, … earlier intervention and biologic treatments, too many people with … 1 of the type I interferon (IFN) receptor, blocking … role, including phase III trials in cutaneous lupus erythematosus, …
-
Tocilizumab for Non-Infectious Uveitis: A Systematic Review
20 Sep 2025 06:04 GMT
… -Stimulating Factor” OR “Interferon beta-2” OR IL6) … infusions require medical supervision and … prospective randomized controlled trials. Logistic regression … drug monitoring of biological agents in non-infectious uveitis treatment: a review. Pharmaceutics …
-
Mortality Due to Covid-19 in Hospitalized Patients: A Prediction Model Based on Different Risk Factors
20 Sep 2025 06:03 GMT
… to increased mortality risk. Treatment with interferon-beta was also reported as … include the absence of medical treatment during the symptomatic phase … covid-19,34,35 stating that regardless of the … above. Another group of drugs are antivirals, such as …
-
The Role of The Xihuang Pill in Inhibiting Triple-Negative Breast Cancer Through Immunogenic Cell Death
05 Sep 2025 13:47 GMT
… ]Abstract: Modern Western medicine uses surgeries, chemotherapy … interferon; IL, interleukin; TLR, toll-like receptor.
The Xihuang pill … experiments with clinical trials to comprehensively … cellular localisation following drug treatment. Cell Stress Chaperones …
-
Lupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made Mandatory
01 Sep 2025 13:23 GMT
… (SEC), under the Central Drugs Standard Control Organisation (CDSCO … the condition that the Interferon-Gamma Release Assay (IGRA … Dose, Single-Period, Two-Treatment, Parallel, Comparative Pharmacokinetics Study … to conduct the clinical trial with the condition …
-
January - March 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
29 Aug 2025 20:22 GMT
… Reactions", and "Medication Guide" sections of the … on available information.
A FDA Drug Safety Communication was issued on … (interferon beta-1b)
Plegridy (pegylated interferon beta-1a)
Rebif (interferon beta-1a)
Injection site abscess
FDA is …
-
Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment
25 Aug 2025 14:05 GMT
… the Food and Drug Administration (FDA) for legal treatment of AGA, … significant advances in the medical treatment of AGA in recent … of interleukin-2 (IL-2), interferon γ (IFN-γ) and other … with finasteride in terms of doctors’ satisfaction, hair density, …
-
Q&A – Advanced RCC: A Potential New Treatment Target
22 Aug 2025 20:42 GMT
… with IL-2 and interferon alpha induced a response … of medicine at Tufts University School of Medicine and medical … caused by the treatment with ICIs. Treatment toxicity may present … Beta pathway modulators.[17] I am particularly interested in an antibody-drug …
-
Beta Interferon Market to Reach USD 5.1 Billion by 2035 | Biogen, Merck, Pfizer Lead – Fact.MR
21 Aug 2025 13:16 GMT
… interferon beta-1a (e.g., Plegridy) have revolutionized treatment … patents for branded drugs.
Beta Interferon Market Demand and … Biotech, Changchun Institute of Biological Products, Hainan Unipul Pharmaceutical, … the U.S. FDA approved its 50th biosimilar …